chondroitin
Small moleculeexperimental
A chondroitin is a chondrin derivative. — Wikipedia
Clinical trial activity
59 trials · 60 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
21
Phase 3
15
Phase 4
11
Earliest trial started Apr 1, 2000 (NCT00032890)
Timeline
Indications
Approved for
Studied for
- Allergy and Immunology · Phase 1
- Anemia, Iron-Deficiency · Phase 4
- Ankle Injuries · Phase 3
- Arthralgia · Phase 2
- Breast Neoplasms · Phase 2
- Cartilage Diseases · Phase 3
- Crohn Disease · Phase 1/Phase 2
- Cystitis · Phase 4
- Cystitis, Interstitial · Phase 2
- Dry Eye Syndromes · Phase 4
- Enterocolitis, Necrotizing · Phase 1
- Healthy Volunteers · Phase 1
- Ischemia · Phase 1
- Joint Diseases · Phase 4
- Kidney Diseases · Phase 4
- Kidney Failure, Chronic · Phase 4
- Ligaments · Phase 3
- Meniscus · Phase 1/Phase 2
- Musculoskeletal Diseases · Phase 4
- Osteoarthritis · Phase 4
- Osteoarthritis, Knee · Phase 4
- Psoriasis · Phase 4
- Renal Dialysis · Phase 4
- Skin Diseases · Phase 4
- Synovitis · Phase 3
- Tears · Phase 1
- Thumb · Phase 4
Mechanism of action
- Chondroitin-6-sulfateSupplementation
Chondroitin-6-sulfate supplementation
Chemistry & pharmacology
Loading structure…
SMILES
CC(=O)N[C@@H]1[C@@H](COC[C@@H]2O[C@H](C(=O)O)[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](CS(=O)(=O)O)[C@@H](CO)O[C@H]1CO- Mol. weight
- 531.53 g/mol
- Lipinski Ro5
- 3 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaChondroitin ↗
- ChEMBLCHEMBL2303614 ↗
- ChEMBLCHEMBL2108922 ↗
Also known as
- chondrogen
- chondroitin
- chondroitin
- chondroitin polysulfate
- chondroitin sulfate
- chondroitin sulfate
- chondroitin sulfate
- chondroitin sulfate
- chondroitin sulfate
- chondroitin sulfates
- chondroitin sulfates
- chondroitin sulfate sodium
- chondroitinsulfuric acid
- chondroitin sulphate
- chondroitin sulphate
- chondroitin sulphate
- chondron
- chondron
- sodium chondroitin sulfate
- sodium chondroitin sulfate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07119645 | N/A | Oct 19, 2025 | Hofseth Biocare ASA |
| NCT06917287 | N/A | Jun 15, 2025 | Vedic Lifesciences Pvt. Ltd. |
| NCT06547424 | Phase 1 | Jan 31, 2025 | Indiana University |
| NCT05687019 | N/A | Sep 12, 2023 | GCS Ramsay Santé pour l’Enseignement et la Recherche |
| NCT05632783 | Phase 3 | Apr 30, 2023 | IBSA Institut Biochimique SA |
| NCT05212259 | N/A | Oct 10, 2022 | Vedic Lifesciences Pvt. Ltd. |
| NCT05474586 | N/A | Aug 8, 2022 | Vedic Lifesciences Pvt. Ltd. |
| NCT06032442 | N/A | Mar 21, 2022 | NPO Petrovax Pharm LLC, St. Petersburg Mechnikov State Medical Academy |
| NCT05321836 | N/A | Jul 26, 2021 | Neuro Counsel Hospital, Pakistan |
| NCT04702776 | Phase 4 | May 1, 2021 | Laboratorios Sophia S.A de C.V. |
| NCT04661267 | N/A | Feb 3, 2021 | Regenexx |
| NCT04470336 | N/A | Jul 9, 2020 | Vedic Lifesciences Pvt. Ltd. |
| NCT04665804 | N/A | Jun 10, 2020 | Foundation University Islamabad |
| NCT05385562 | N/A | Jan 2, 2020 | Al Azhar University |
| NCT04423432 | N/A | Jan 1, 2020 | Foundation University Institute of Rehabilitation Sciences, Foundation University Islamabad, Isra University |
| NCT04654871 | N/A | Jan 1, 2020 | Foundation University Islamabad |
| NCT03936192 | Phase 3 | Oct 1, 2019 | Eurofarma Laboratorios S.A. |
| NCT04070677 | N/A | Jun 15, 2019 | Grupo de Investigación Clínica en Oncología Radioterapia, Norgine |
| NCT03697876 | Phase 1 | Sep 30, 2018 | Laboratorios Sophia S.A de C.V. |
| NCT03963323 | Phase 1 | May 11, 2018 | University of Washington |
Showing 20 of 59 trials
Page 1 / 3
Organizations
Research & Development (60)
60 organizations
Page 1 / 3